Evidence map›Paper›PMID 41884392›Full record

ReviewClinical, cosmetic and investigational dermatology2026

An Overview of the Treatment of Onychomycosis in Patients with Diabetes: Current Pharmacological and Non-Pharmacological Options.

Yizhe Li, Jieyuzhen Qiu, Yi Shen, Wen Tan, Jing Zhang

Abstract readReview
In one paragraph

Review in Clinical, cosmetic and investigational dermatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yizhe Li *Department of Endocrinology, Huadong Hospital, Fudan University, Shanghai, 200040, People's Republic of China.
Jieyuzhen Qiu *Department of Endocrinology, Huadong Hospital, Fudan University, Shanghai, 200040, People's Republic of China.
Yi ShenDepartment of Geriatrics, Huadong Hospital, Fudan University, Shanghai, 200040, People's Republic of China.
Wen TanDepartment of Endocrinology, Huadong Hospital, Fudan University, Shanghai, 200040, People's Republic of China.
Jing ZhangDepartment of Endocrinology, Huadong Hospital, Fudan University, Shanghai, 200040, People's Republic of China.ORCID 0000-0001-6035-5311

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Onychomycosis exhibits a high incidence in patients with diabetes, and its treatment is often challenging and prone to recurrence due to specific pathophysiological factors (such as impaired immune function and microcirculatory disorders). It can also lead to serious complications such as foot infections. This review systematically examines the therapeutic options specifically for diabetic onychomycosis. We will review traditional treatment methods, including oral and topical antifungal drugs, with a particular focus on their safety and drug-drug interactions. Besides, we also explored emerging new therapeutic strategies, such as laser therapy, photodynamic therapy (PDT), and surgical approaches. By integrating current clinical data, this review aims to provide clinicians with a more comprehensive and effective approach to treatment, with the goal of improving the clinical outcomes and quality of life for patients with diabetic onychomycosis.

Indexed as

diabetic onychomycosisepidemiologyoral antifungal medicationstopical antifungal drugstreatment

Identifiers

PMID41884392
PMCPMC13011845

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.